Drug Database · Clinicians

Paracetamol + Tramadol

Also known as: acetaminophen (US name, for paracetamol)

Brands (87) Trampa, Adolpan, Dologesic…Show all

US brand (reference label): Tramadol Hydrochloride and Acetaminophen; not a Philippine-registered brand.

Analgesic/Antipyretic/Opioid analgesic; Analgesic/Antipyretic/ anti-inflammatory; and others PH FDA category
Fixed-dose combination.

Rx · Prescription drug112 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 244f6e5d-e1b4-ba8b-ca6f-af2d8a31d5f0, version date January 12, 2026 (Tramadol Hydrochloride and Acetaminophen · AvPAK). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • INDICATIONS AND USAGE Tramadol hydrochloride and acetaminophen tablets, USP are indicated for the short-term (five days or less) management of acute pain.
US FDA label
Full indications and usage US FDA label

INDICATIONS AND USAGE Tramadol hydrochloride and acetaminophen tablets, USP are indicated for the short-term (five days or less) management of acute pain.

Contraindications

CONTRAINDICATIONS Tramadol hydrochloride and acetaminophen tablets, USP should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, USP, acetaminophen, USP, any other component of this product, or opioids. Tramadol hydrochloride and acetaminophen tablets, USP are contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids, or psychotropic drugs.

Tramadol hydrochloride and acetaminophen tablets, USP may worsen central nervous system and respiratory depression in these patients.

US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label

DOSAGE AND ADMINISTRATION For the short-term (five days or less) management of acute pain, the recommended dose of tramadol hydrochloride and acetaminophen tablets, USP is 2 tablets every 4 to 6 hours as needed for pain relief, up to a maximum of 8 tablets per day. Individualization of Dose In patients with creatinine clearances of less than 30 mL/min, it is recommended that the dosing interval of tramadol hydrochloride and acetaminophen tablets, USP be increased not to exceed 2 tablets every 12 hours.

Dose selection for an elderly patient should be cautious, in view of the potential for greater sensitivity to adverse events.

Dosing: Altered kidney function

From the US FDA label · Dosage and administration (renal excerpts)

DOSAGE AND ADMINISTRATION For the short-term (five days or less) management of acute pain, the recommended dose of tramadol hydrochloride and acetaminophen tablets, USP is 2 tablets every 4 to 6 hours as needed for pain relief, up to a maximum of 8 tablets per day. Individualization of Dose In patients with creatinine clearances of less than 30 mL/min, it is recommended that the dosing interval of tramadol hydrochloride and acetaminophen tablets, USP be increased not to exceed 2 tablets every 12 hours. Dose selection for an elderly patient should be cautious, in view of the potential for greater sensitivity to adverse events.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Film-coated tablet: 18.75 mg/162.50 mg, 32 g mg/37.5 mg, 37.5 mg/325 mg, 325 mg/37.5 mg
  • Tablet: 37.5 mg/325 mg, 325 mg/37.5 mg
  • Effervescent tablet: 37.5 mg/325 mg, 325 mg/37.5 mg
  • Per film-caoted tablet: 37.5 mg/325 mg
  • Per film-coated tablet: 37.5 mg/325 mg

Registered products in the Philippines

112 products registered with the Food and Drug Administration (FDA) Philippines list Paracetamol + Tramadol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products112
Philippine FDA-registered products for Paracetamol + Tramadol
Package insert
AdolpanTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's)
Rx
Pharmix Laboratories (Pvt) Ltd)Pakistan
Sahar International Trading Inc.
DR-XY49125
Jul 5, 2029
AdolpanTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's)
Rx
Pharmix Laboratories (Pvt.) Ltd.Pakistan
Sahar International Trading, Inc.
DRP-17773
Jul 5, 2029
AlgesiaParacetamol + Tramadol Hydrochloride
325 mg / 37.5 mg Film-Coated TabletAlu / PVC Blister Pack x 10's (Box of 20's); Alu / PVC Blister Pack x 10's (Box of 50's)
Rx
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY34809
Aug 15, 2028
AltotramParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's and 100's
Rx
Stallion Laboratories Pvt. Ltd.India
Altomed Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-5195-01
Mar 3, 2028
AmacetTramadol hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletPVC/Alu Blister Pack x 10’s Box of 50’s; PVC/Alu Blister Pack x 10’s Box of 100’s
Rx
SAMJIN PHARMACEUTICAL CO., LTD.Republic of Korea
PHARMA KING DISTRIBUTORImporter: UNIMEX, INC.
DRP-3380
May 17, 2029
Ambidol-PParacetamol + Tramadol HCl
325 mg/ 37.5 mg Film-Coated TabletAlu/ Clear PVC-PVDC Blister Pack x 10's ( Box of 100's )
Rx
—
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-11487-02
Mar 16, 2027
Aptradol PlusParacetamol + Tramadol
325 mg/37.5 mg Film-Coated TabletAlu/PVC Clear Blister Pack x 10's (Box of 30's & 100's)
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-16949
Aug 29, 2030
AradolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Effervescent TabletAluminum Strip Foil x 4's (Box of 6 blister packs x 4 effervescent tablet)
Rx
Vovantis Laboratories Private LimitedIndia
Aglobal Care, Inc.Trader: Asence Pharma Private Limited
DRP-13615
Mar 17, 2028
BelcetraParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Samchundang Pharm. Co., Ltd.Republic of Korea
Oxpharm Inc.Importer: GPC Geo Pharma Corporation
DRP-5082-04
Feb 28, 2029
CalmadolParacetamol + Tramadol Hydrochloride
325 mg/ 37.5 mg Film-Coated TabletAlu/Clear PVC//PVDC Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Bulacan
GX International, Inc.Trader: D.B Manix International, Inc.
DRP-17849-01
Sep 30, 2030
Calmol TTramadol Hydrochloride + Paracetamol
37.5 mg/ 325 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Rhydburg Pharmaceuticals LimitedIndia
Healthwinds Medical Trading Corp.Importer: Pharmastar Int'l Trading Corp.
DRP-15076-01
Apr 16, 2029
CepremolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu / Clear PVC Blister Pack x 10's (Box of 30's & 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5183-14
Feb 25, 2029
CetadolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Samchundang Pharm. Co. Ltd.Republic of Korea
Bell-Kenz Pharma Inc.Importer: GPC Geo Pharma Corporation
DRP-5082
Feb 28, 2029
CetamadolTramadol hydrochloride + Paracetamol
37.5 mg / 325 mg Film-Coated TabletPVC/Alu Blister Pack x 10’s Box of 50’s; PVC/Alu Blister Pack x 10’s Box of 100’s
Rx
SAMJIN PHARMACEUTICAL CO., LTD.Republic of Korea
PHARMAZEL, INC.Importer: UNIMEX, INC.
DRP-3380-02
May 17, 2029
CetodolTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg tabletAlu/PVDC Blister Pack x10's (Box of 50's and 100's)
Rx
Micro Labs LimitedIndia
Brown & Burk Phils., Inc.
DRP-932
Mar 7, 2028
CetraTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg TabletAlu/PVDC Blister Pack x 10's (Box of 100's)
Rx
Micro Labs LimitedIndia
ADP Pharma CorporationImporter: Brown & Burk Phils., Inc.
DRP-932-01
Mar 7, 2028
CetradolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's); Alu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Euroasia Pharmaceuticals, Inc.Importer: Pharmakon Biotec Inc.
DRP-5183-01
Feb 25, 2029
DamadolTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100 tablets)
Rx
Rhydburg Pharmaceuticals LimitedIndia
Genedrift Philippines OPC
DRP-15075
Apr 16, 2029
DolcephilTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Phil Asia Pharma, Inc.Importer: Ambica International Corporation
DRP-3309-11
Oct 14, 2029
DolceplusTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-3309-04
Oct 14, 2029
DolcetTramadol + Paracetamol
37.5 mg/325 mg TabletWhite PVC/Alu Blister Pack x 10's (Box of 50's)
Rx
Janssen Cilag S.p.A.Italy
Zuellig Pharma CorporationImporter: Johnson & Johnson (Philippines), Inc.
DR-XY35024
Oct 13, 2028
Dolcet MiniTramadol Hydrochloride + Paracetamol
18.75 mg/ 162.50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 50's)
Rx
Handok Inc.Korea
Johnson & Johnson (Philippines), Inc.
DR-XY48770
Jan 16, 2031
DolcetalParacetamol + Tramadol Hydrochloride
325 mg / 37.5 mg Film-Coated TabletAluminum Foil Strip x 10's Box of 100's
Rx
Lloyd Laboratories, Inc.Philippines
TGP PHARMA INC.Trader: DB Manix International, Inc.
DRP-1929-01
May 11, 2029
DolferParacetamol + Tramadol
325 mg/37.5 mg TabletAlu/PVC Clear Blister Pack x 10's (Box of 30's & 100's)
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
Ferma Drug Enterprises
DRP-16949-03
Aug 29, 2030
DologesicParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Randril Internation Co., Inc.
DR-XY47074
Sep 30, 2031
DologesicTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg per Film-Caoted TabletFoil Strip x 10's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Randril International Co., Inc.
DRP-4246
Jul 31, 2027
Dolpain PlusParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Prodrom Nutritionals, IncImporter: Ambica International Corporation
DRP-5844-02
Dec 1, 2029
Dolright PlusParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's Box of 100's
Rx
XL Laboratories Pvt. Ltd.India
Neo-Care PhilippinesImporter: Ambica International Corporation
DRP-5844-01
Dec 1, 2029
DolsaphParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Genom Biotech Pvt Ltd.India
Nelpa Lifesciences Inc.
DRP-5171
Feb 9, 2031
Duo-gesicParacetamol + Tramadol HCl
325 mg/ 37.5 mg Film-Coated TabletAlu/ Clear PVC-PVDC Blister Pack x 10's (Box of 100's)
Rx
Fredun Pharmaceuticals LimitedIndia
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-11487-01
Mar 16, 2027
DuocetzTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 30's)
Rx
Mega Lifesciences Public Company LimitedThailand
Metro Drug,Inc.Importer: Mega Lifesciences Limited Inc.Trader: Mega Lifesciences (Australia) Pty. Ltd.
DR-XY45759
Jan 26, 2032
DuotramParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's); Alu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Pharmakon Biotec Inc.
DRP-5183
Feb 25, 2029
FemadolParacetamol + Tramadol Hydrochloride
325 mg / 37.5 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100’s)
Rx
Lloyd Laboratories, Inc.Philippines
West Wing Pharma Sales Inc.Trader: D.B. MANIX INTERNATIONAL, INC.
DRP-1929-06
May 11, 2029
FevcetParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
D&G PharmaImporter: Ambica International Corporation
DRP-5195-05
Mar 3, 2028
FevcetTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
D&G PharmaImporter: Ambica International Corporation
DRP-3309-08
Oct 14, 2029
Gentradol PlusParacetamol + Tramadol
325 mg /37.5 mg TabletAlu/PVC Clear Blister Pack x 10's (Box of 100's)
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-16949-05
Aug 29, 2030
GeocetParacetamol + Tramadol Hydrochloride
325mg/37.5mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Samchundang Pharm. Co., Ltd.Republic of Korea
Heka Enterprise Inc.Importer: GPC Geo Pharma Corporation
DRP-5082-01
Feb 28, 2029
GoracetParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 50's and 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Ambica International Corporation
DRP-5195-09
Mar 3, 2028
GoracetTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Ambica International Corporation
DRP-3309-01
Oct 14, 2029
Lotram PlusParacetamol + Tramadol Hydrochloride
325 mg/ 37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Rhydburg Pharmaceuticals LimitedIndia
Trumed PharmaceuticalsImporter: Hexagon Pharmaceuticals
DRP-7123-01
Mar 23, 2027
MedracetTramadol hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletPVC/Alu Blister Pack x 10’s (Box of 50’s); PVC/Alu Blister Pack x 10’s (Box of 100’s)
Rx
SAMJIN PHARMACEUTICAL CO., LTD.Republic of Korea
MEDBRIDGE, INC.Importer: UNIMEX, INC.
DRP-3380-01
May 17, 2029
NavcetraParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
JNC Pharmaceuticals CorporationImporter: Pharmakon Biotec, Inc.
DRP-5183-16
Feb 25, 2029
NoneParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's)
Rx
Magbro Healthcare Pvt. Ltd.India 174101
Reta DrugImporter: Pharmakon Biotec Inc.
DRP-5183-17
Feb 25, 2029
NoneParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's)
Rx
Stallion Laboratories Pvt. Ltd.India
ATC Healthcare International Corp.Importer: Ambica International Corporation
DRP-5195-03
Mar 3, 2028
NoneParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's and 50's
Rx
Stallion Laboratories Pvt. Ltd.India
Watsons Personal Care Stores (Philippines), Inc.Importer: Ambica International Corporation
DRP-5195-04
Mar 3, 2028
NoneParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's, 50's and 100's
Rx
Stallion Laboratories Pvt. Ltd.India
Actimed, Inc.Importer: Ambica International Corporation
DRP-5195-07
Mar 3, 2028
NoneParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC/PVdC Blister Pack x 10's
Rx
Lloyd Laboratories, Inc.Philippines
Getz Pharma (Phils.). Inc.Trader: Innogen Pharmaceuticals, Inc.
DRP-9985
Aug 30, 2028
NoneParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Medico Remedies LimitedIndia
Actimed, Inc.Importer: Medethix, Inc.
DRP-14042-02
Jun 8, 2031
NoneParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Medico Remedies LimitedIndia
I.E. Medica, Inc.Importer: Medethix, Inc.
DRP-14042-03
Mar 15, 2031
NoneTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Actimed, Inc.Importer: Ambica International Corporation
DRP-3309-03
Oct 14, 2029
NoneTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Watsons Personal Care Stores (Philippines) Inc.Importer: Ambica International Corporation
DRP-3309-10
Oct 14, 2029
NoneTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Ritemed Phils., Inc.Importer: Ambica International Corporation
DRP-3309-12
Oct 14, 2029
NoneTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's and 100's)
Rx
Hizon Laboratories, Inc.Philippines
Actimed, Inc.
DRP-7603
Jun 4, 2031
NoneTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's)
Rx
Hizon Laboratories, Inc.Philippines
S.V. More Pharma Corporation
DRP-7603-05
Jun 17, 2031
NutramParacetamol + Tramadol (as hydrochloride)
325 mg/37.5 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30’s)
Rx
Daewoong Pharmaceutical Co., Ltd.Republic of Korea
S.V. More Pharma CorporationImporter: Daewoong Pharma Phils.
DR-XY40688
Feb 27, 2027
OprycetParacetamol + Tramadol Hydrochloride
325 mg / 37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5183-12
Feb 25, 2029
Orantrama PTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 30’s)
Rx
Theon Pharmaceuticals Ltd.India
Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-3192-03
Aug 22, 2031
Orpar ForteParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
Rx
Stallion Laboratories Pvt. Ltd.India
Pharmasilv TradingImporter: Ambica International Corporation
DRP-5195-10
Mar 3, 2028
P-DolTramadol Hydrochloride + Paracetamol
37.5 mg / 325 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 30’s)
Rx
Theon Pharmaceuticals Ltd.India
Multicare Pharmaceuticals Phils. Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-3192
Apr 22, 2031
ParadolcetTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu-PVC Blister Pack of 10’s (Box of 30’s and 100’s)
Rx
Rhydburg Pharmaceuticals LimitedIndia
Medinova Pharmaceutical Inc.
DRP-18858
Sep 21, 2031
ParatramTramadol Hydrochloride + Paracetamol
37.5 mg / 325 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 30’s)
Rx
Theon Pharmaceuticals Ltd.India
GETZ PHARMA (PHILS.), INC.Importer: Suhitas Pharmaceuticals Inc.
DRP-3192-01
Aug 22, 2031
ParatramTramadol hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/Alu Blister Pack of x 10's (Box of 30's)
Rx
Getz Pharma Pvt. Ltd.Pakistan
Getz Pharma (Phils.) Inc.,
DRP-15515
Jul 30, 2029
PatraphilTramadol hydrochloride + Paracetamol
37.5 mg/325 mg Film Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's)
Rx
Baroque Pharmaceuticals Pvt. Ltd.India
AMB HK Enterprises Inc.
DRP-17750
Mar 5, 2031
PatrasanParacetamol + Tramadol hydrochloride
325 mg/37.5 mg Effervescent TabletAluminum Strip Foil x 4's (Box of 6 blister packs x 4 effervescent tablet)
Rx
Vovantis Laboratories Private LimitedIndia
Sannovex Pharmaceutical DistributorImporter: Aglobal Care, Inc.Trader: Asence Pharma Private Limited
DRP-13615-02
Mar 17, 2028
PatrazenParacetamol + Tramadol
325 mg/37.5 mg TabletAlu/PVC Clear Blister Pack x 10's (Box of 30's & 100's)
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
Kodapharm Med Corp.
DRP-16949-06
Aug 29, 2030
Penradol PlusParacetamol + Tramadol
325 mg/37.5 mg TabletAlu/PVC Clear Blister Pack x 10's (Box of 30's & 100's)
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-16949-04
Aug 29, 2030
PradolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Vamsler Phils. Incorporated
DR-XY47075
Sep 30, 2031
PradolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated Tablet
Rx
Lloyd Laboratories, Inc.
Trader: Vamsler Phils. Incorporated
DRP-8189
Dec 5, 2026
PrimetramParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Life and Health Source Pharmaceutical Distribution Co.Importer: Pharmakon Biotec Inc.
DRP-5183-04
Feb 25, 2029
PromadolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
Rx
Stallion Laboratories Pvt. Ltd.India
Speed Cure PharmaImporter: Ambica International Corporation
DRP-5195-06
Mar 3, 2028
PromadolTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Speed Cure PharmaImporter: Ambica International Corporation
DRP-3309-09
Oct 14, 2029
ProvidolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAluminum foil strip x 10's (Box of 100’s)
Rx
Lloyd Laboratories, Inc.Philippines
Providencia Medica, Inc.Trader: DB Manix International, Inc.
DRP-1929-02
May 11, 2029
PTRATramadol Hydrochloride + Paracetamol
37.5 mg/ 325 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 30’s)
Rx
Theon Pharmaceuticals Ltd.India
Preventia Healthcare Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-3192-02
Aug 22, 2031
RacedolParacetamol + Tramadol Hydrochloride
325 mg / 37.5 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100’s)
Rx
Lloyd Laboratories, Inc.Philippines
Medirich Pharma Distribution Corp.Trader: D.B. MANIX INTERNATIONAL, INC.
DRP-1929-03
May 11, 2029
RamalParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100’s)
Rx
Lloyd Laboratories, Inc.Philippines
RL Pharma Enterprises Inc.Trader: D.B. Manix International, Inc.
DRP-1929-08
May 11, 2029
Rapamol TTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100 tablets)
Rx
Rhydburg Pharmaceuticals LimitedIndia
Genedrift Philippines OPC
DRP-15076
Apr 16, 2029
Recedol PlusParacetamol + Tramadol Hydrochloride
325 mg/ 37.5 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
Rx
Medico Remedies LimitedIndia
Labmate Pharma Inc.Importer: Medethix, Inc.
DRP-14042
Mar 15, 2031
Recedol PlusParacetamol + Tramadol hydrochloride
325 mg/37.5 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Sydler Remedies Pvt. LimitedIndia
Labmate Pharma Inc.Importer: Medethix, Inc.
DRP-4334
Dec 19, 2030
RegixantParacetamol + Tramadol
325 mg / 37.5 mg TabletAlu/PVC Clear Blister Pack x 10's (Box of 30's & 100's)
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-16949-02
Aug 29, 2030
ReliefsycTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Diafarm, Inc.Importer: Ambica International Corporation
DRP-5844-03
Dec 1, 2029
RelitramParacetamol+tramadol HCL
325 mg/37.5 mg Film-coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's & 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading IncImporter: Pharmakon Biotec Inc.
DRP-5183-15
Feb 25, 2029
RemedolTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
Rx
Hiral Labs LimitedIndia
Medinova Pharmaceutical Inc.
DRP-17788
Mar 10, 2031
RinellaParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Jjysrinn Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5183-03
Feb 25, 2029
StandolTramadol hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Standard Chem. & Pharm. Co., Ltd.Taiwan
Standard Chem & Pharm. Philippines, Inc.
DRP-11156
Feb 22, 2032
SupercetTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg per Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
KOREA UNITED PHARM. INC.Korea
QUALIMED PHARMA INC.
DR-XY39006
Feb 1, 2028
TamolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletFoil Strip x 10 's Box of 100's
Rx
Lloyd Laboratories, Inc.Philippines
Vispomed EnterprisesTrader: Vamsler Phils. Incorporated
DRP-8189-01
Dec 5, 2026
TDL® PlusTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletPVC/Alu Blister Pack x 10’s (Box of 50’s and 100's)
Rx
Samjin Pharmaceutical Co., Ltd.Republic of Korea
Patriot Pharmaceuticals CorporationImporter: Unimex, Inc.
DRP-3380-03
May 17, 2029
TracelParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
PHILIPPINE HOME PHARMACEUTICALSTrader: D.B. MANIX INTERNATIONAL, INC.
DRP-1929-04
May 11, 2029
TracemolTramadol hydrochloride + Paracetamol
37.5 mg/325 mg Effervescent TabletAlu/Alu Strip Pack x 4’s (Box of 32's)
Rx
Vovantis Laboratories Pvt. Ltd.India
SRS Life Sciences Inc.Trader: SRS Pharmaceuticals Pvt. Ltd.
DR-XY46992
Aug 7, 2031
TracyTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletFoil Strip x 10's (Box of 30's and 100's)
Rx
Lloyd Laboratories, Inc.Philippines
Innogen Pharmaceuticals, Inc.Trader: Randril International Co., Inc.
DRP-4246-02
Jul 31, 2027
TradoxoParacetamol + Tramadol hydrochloride
325 mg/ 37.5 mg Effervescent TabletAluminum Strip Foil x 4's (Box of 6 Blister Packs x 4 effervescent tablet)
Rx
VOVANTIS LABORATORIES PRIVATE LIMITEDIndia
THE CATHAY DRUG CO., INC.Importer: AGLOBAL CARE, INC.Trader: ASENCE PHARMA PRIVATE LIMITED
DRP-13615-01
Mar 17, 2028
Tramadin PlusTramadol hydrochloride + Paracetamol
37.5 mg/325 mg Film-coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Korea Pharma Co., Ltd.Republic of Korea
Justright Healthcare Inc.
DR-XY44377
Apr 7, 2030
Tramalion-PParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 50's and 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-5195
Mar 3, 2028
TramasethParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Sapphire Lifesciences Pvt. Ltd.India
777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.
DRP-5171-01
Feb 11, 2029
TramelaxParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Excelcare Inc.Importer: Ambica International Corporation
DRP-5844
Dec 1, 2029
TramicetTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
WEST WING PHARMA SALES INC.Importer: Ambica International Corporation
DRP-3309-07
Oct 14, 2029
TramocetTramadol Hydrochloride + Paracetamol
37.5 mg / 325mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100 tablets)
Rx
Rhydburg Pharmaceuticals LimitedIndia
Tazio Lifescience Inc.Importer: Pharmastar Int'l Trading Corp.
DRP-15076-02
Apr 16, 2029
TrampaParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Pharmspec N.A., Inc.Trader: D.B. Manix International, Inc.
DR-XY47076
Sep 30, 2030
TrampaParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: D.B. Manix International, Inc.
DRP-17849
Sep 30, 2030
TrampaParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100’s)
Rx
Lloyd Laboratories, Inc.Philippines
PHARMASPEC N.A., INC.Trader: DB Manix International Inc.
DRP-1929
May 11, 2029
TrapTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu-PVDC/PVC Blister Pack of 10's Box of 100's
Rx
Cadila Healthcare LimitedIndia
Zydus Healthcare Philippines Inc.
DRP-7309
Nov 20, 2027
TrapadixParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5183-02
Feb 25, 2029
TrapadolTramadol Hydrochloride + Paracetamol
37.5 mg / 325 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 30’s)
Rx
Theon Pharmaceuticals Ltd.India
Littman Drug CorporationImporter: Suhitas Pharmaceuticals Inc.
DRP-3192-05
Aug 22, 2031
TretamolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100’s)
Rx
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-5195-08
Mar 3, 2028
Trump PlusParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's and 50's
Rx
Stallion Laboratories Pvt. Ltd.India
Alkem Laboratories CorporationImporter: Ambica International Corporation
DRP-5195-02
Mar 3, 2028
TyramolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's); Alu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5183-13
Feb 25, 2029
UnbrandedParacetamol + Tramadol Hydrochloride
32g mg / 37.5 mg Film-Coated TabletAluminum Foil Strip x 10's Box of 100’s
Rx
Lloyd Laboratories, Inc.Philippines
Euro-Health Care Exponents, Inc.Trader: D.B. MANIX INTERNATIONAL, INC.
DRP-1929-07
May 11, 2029
UnbrandedTramadol hydrochloride + Paracetamol
37.5 mg/325 mg TabletAluminum foil strip x 10 tablets (Box of 100 tablets)
Rx
Troikaa Pharmaceuticals LimitedIndia
RITEMED PHILS., INC.
DRP-10652
Oct 29, 2031
VintramolParacetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
VINCARE PHARMATrader: D.B. MANIX INTERNATIONAL, INC.
DRP-1929-05
May 11, 2029
VistramolTramadol Hydrochloride + Paracetamol
37.5 mg/325 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-3309-06
Oct 14, 2029
ZandolParacetamol + Tramadol
325 mg/ 37.5 mg TabletAlu/PVC Clear Blister Pack x 10's (Box of 30's & 100's)
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
Triple 888 Medical And Pharma Inc.
DRP-16949-01
Aug 29, 2030
(no brand name)Paracetamol + Tramadol Hydrochloride
325 mg/37.5 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 100's)
Rx
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-15592
Aug 14, 2029

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

WARNINGS Hepatotoxicity Tramadol hydrochloride and acetaminophen tablets contain tramadol hydrochloride and acetaminophen. Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4,000 milligrams per day, and often involve more than one acetaminophen-containing product.

The excessive intake of acetaminophen may be intentional to cause self-harm or unintentional as patients attempt to obtain more pain relief or unknowingly take other acetaminophen-containing products (see Boxed Warning). The risk of acute liver failure is higher in individuals with underlying liver disease and in individuals who ingest alcohol while taking acetaminophen.

Instruct patients to look for acetaminophen or APAP on package labels and not to use more than one product that contains acetaminophen. Instruct patients to seek medical attention immediately upon ingestion of more than 4,000 milligrams of acetaminophen per day, even if they feel well. Serious Skin Reactions Rarely, acetaminophen may cause serious skin reactions such as acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson Syndrome (SJS), and toxic epidermal necrolysis (TEN), which can be fatal.

Patients should be informed about the signs of serious skin reactions, and use of the drug should be discontinued at the first appearance of skin rash or any other sign of hypersensitivity. Seizure Risk Seizures have been reported in patients receiving tramadol within the recommended dosage range. Spontaneous postmarketing reports indicate that seizure risk is increased with doses of tramadol above the recommended range.

Concomitant use of tramadol increases the seizure risk in patients taking: Selective serotonin reuptake inhibitors (SSRI antidepressants or anorectics), Tricyclic antidepressants (TCAs), and other tricyclic compounds (e.g., cyclobenzaprine, promethazine, etc.), or Other opioids. Administration of tramadol may enhance the seizure risk in patients taking: MAO inhibitors (see also WARNINGS, Use with MAO Inhibitors and Serotonin Re-uptake Inhibitors), Neuroleptics, or Other drugs that reduce the seizure threshold.

Risk of convulsions may also increase in patients with epilepsy, those with a history of seizures, or in patients with a recognized risk for seizure (such as head trauma, metabolic disorders, alcohol and drug withdrawal, or CNS infections). In tramadol overdose, naloxone administration may increase the risk of seizure. Suicide Risk Do not prescribe tramadol hydrochloride and acetaminophen tablets for patients who are suicidal or addiction-prone.

Prescribe tramadol hydrochloride and acetaminophen tablets with caution for patients taking tranquilizers or antidepressant drugs and patients who use alcohol in excess and who suffer from emotional disturbance or depression. The judicious prescribing of tramadol is essential to the safe use of this drug. With patients who are depressed or suicidal, consideration should be given to the use of non-narcotic analgesics.

Tramadol-related deaths have occurred in patients with previous histories of emotional disturbances or suicidal ideation or attempts as well as histories of misuse of tranquilizers, alcohol, and other CNS-active drugs (see WARNINGS, Risk of Overdosage). Serotonin Syndrome Risk The development of a potentially life-threatening serotonin syndrome may occur with the use of tramadol products, including tramadol hydrochloride and acetaminophen tablets, particularly with concomitant use of serotonergic drugs such as SSRIs, SNRIs, TCAs, MAOIs, and triptans, with drugs which impair metabolism of serotonin (including MAOIs), and with drugs which impair metabolism of tramadol (CYP2D6 and CYP3A4 inhibitors).

This may occur within the recommended dose (see CLINICAL PHARMACOLOGY, Pharmacokinetics). Serotonin syndrome may include mental-status changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g., tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations (e.g., hyperreflexia, incoordination), and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea).

Hypersensitivity/Aaphylaxis Serious and rarely fatal anaphylactic reactions have been reported in patients receiving therapy with tramadol. When these events do occur it is often following the first dose. Other reported allergic reactions include pruritus, hives, bronchospasm, angioedema, toxic epidermal necrolysis and Stevens-Johnson syndrome.

Patients with a history of anaphylactoid reactions to codeine and other opioids may be at increased risk and therefore should not receive tramadol hydrochloride and acetaminophen tablets (see CONTRAINDICATIONS). There have been postmarketing reports of hypersensitivity and anaphylaxis associated with the use of acetaminophen.

Clinical signs included swelling of the face, mouth, and throat, respiratory distress, urticaria, rash, pruritus, and vomiting. There were infrequent reports of life-threatening anaphylaxis requiring emergency medical attention. Instruct patients to discontinue tramadol hydrochloride and acetaminophen tablets immediately and seek medical care if they experience these symptoms.

Do not prescribe tramadol hydrochloride and acetaminophen tablets for patients with acetaminophen allergy. Respiratory Depression Administer tramadol hydrochloride and acetaminophen tablets cautiously in patients at risk for respiratory depression. In these patients, alternative non-opioid analgesics should be considered.

When large doses of tramadol are administered with anesthetic medications or alcohol, respiratory depression may result. Respiratory depression should be treated as an overdose. If naloxone is to be administered, use cautiously because it may precipitate seizures (see WARNINGS, Seizure Risk and OVERDOSAGE). Interaction with Central Nervous System (CNS) Depressants Tramadol hydrochloride and acetaminophen tablets should be used with caution and in reduced dosages when administered to patients receiving CNS depressants such as alcohol, opioids, anesthetic agents, narcotics, phenothiazines, tranquilizers or sedative hypnotics.

Tramadol increases the risk of CNS and respiratory depression in these patients. Interactions with Alcohol and Drugs of Abuse Tramadol may be expected to have additive effects when used in conjunction with alcohol, other opioids, or illicit drugs that cause central nervous system depression. Increased Intracranial Pressure or Head Trauma Tramadol hydrochloride and acetaminophen tablets should be used with caution in patients with increased intracranial pressure or head injury.

The respiratory depressant effects of opioids include carbon dioxide retention and secondary elevation of cerebrospinal fluid pressure and may be markedly exaggerated in these patients. Additionally, pupillary changes (miosis) from tramadol may obscure the existence, extent, or course of intracranial pathology. Clinicians should also maintain a high index of suspicion for adverse drug reactions when evaluating altered mental status in these patients if they are receiving tramadol hydrochloride and acetaminophen tablets (see WARNINGS, Respiratory Depression).

Use in Ambulatory Patients Tramadol may impair the mental and or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. The patient using this drug should be cautioned accordingly. Use With MAO Inhibitors and Serotonin Re-uptake Inhibitors Use tramadol hydrochloride and acetaminophen tablets with great caution in patients taking monoamine oxidase inhibitors.

Animal studies have shown increased deaths with combined administration of MAO inhibitors and tramadol. Concomitant use of tramadol with MAO inhibitors or SSRIs increases the risk of adverse events, including seizure and serotonin syndrome. Use With Alcohol Tramadol hydrochloride and acetaminophen tablets should not be used concomitantly with alcohol consumption.

The use of tramadol hydrochloride and acetaminophen tablets in patients with liver disease is not recommended. Use With Other Acetaminophen-containing Products Due to the potential for acetaminophen hepatotoxicity at doses higher than the recommended dose, tramadol hydrochloride and acetaminophen tablets should not be used concomitantly with other acetaminophen-containing products.

Misuse, Abuse and Diversion Tramadol has mu-opioid agonist activity. Tramadol hydrochloride and acetaminophen tablets, a tramadol-containing product, can be sought by drug abusers and people with addiction disorders and may be subject to criminal diversion. The possibility of illegal or illicit use should be considered when prescribing or dispensing tramadol hydrochloride and acetaminophen tablets in situations where the physician or pharmacist is concerned about an increased risk of misuse, abuse, or diversion.

Misuse or abuse poses a significant risk to the abuser that could result in overdose and death (see DRUG ABUSE AND DEPENDENCE and OVERDOSAGE). Concerns about abuse, addiction, and diversion should not prevent the proper management of pain. The development of addiction to opioid analgesics in properly managed patients with pain has been reported to be rare.

However, data are not available to establish the true incidence of addiction in chronic pain patients. Risk of Overdosage Patients taking tramadol should be warned not to exceed the dose recommended by their physician. Tramadol products in excessive doses, either alone or in combination with other CNS depressants, including alcohol, are a cause of drug-related deaths.

Patients should be cautioned about the concomitant use of tramadol products and alcohol because of potentially serious CNS additive effects of these agents. Because of its added depressant effects, tramadol should be prescribed with caution for those patients whose medical condition requires the concomitant administration of sedatives, tranquilizers, muscle relaxants, tricyclic antidepressants, or other CNS depressant drugs.

Patients should be advised of the additive depressant effects of these combinations. Serious potential consequences of overdosage with tramadol are central nervous system depression, respiratory depression, and death. Some deaths have occurred as a consequence of the accidental ingestion of excessive quantities of tramadol alone or in combination with other drugs.

In treating an overdose, primary attention should be given to maintaining adequate ventilation along with general supportive treatment (see OVERDOSAGE). A serious potential consequence of overdosage with acetaminophen is hepatic (centrilobular) necrosis, leading to hepatic failure and death. Emergency help should be sought immediately and treatment initiated immediately if overdose is suspected, even if symptoms are not apparent.

Withdrawal Withdrawal symptoms may occur if tramadol hydrochloride and acetaminophen tablets are discontinued abruptly (see also DRUG ABUSE AND DEPENDENCE). Reported symptoms have included anxiety, sweating, insomnia, rigors, pain, nausea, tremors, diarrhea, upper respiratory symptoms, piloerection, and rarely hallucinations.

Other symptoms that have been reported less frequently with tramadol hydrochloride and acetaminophen tablet discontinuation include: panic attacks, severe anxiety, and paresthesias. Clinical experience suggests that withdrawal symptoms may be avoided by tapering tramadol hydrochloride and acetaminophen tablets at the time of discontinuation.

Drug interactions

Metabolism and transporters (CYP, P-gp, OATP; US label) US FDA label

Metabolism Following oral administration, tramadol is extensively metabolized by a number of pathways, including CYP2D6 and CYP3A4, as well as by conjugation of parent and metabolites.

Formation of M1 is dependent on CYP2D6 and as such is subject to inhibition, which may affect the therapeutic response (see PRECAUTIONS, Drug Interactions ).

Approximately 7% of the population has reduced activity of the CYP2D6 isoenzyme of cytochrome P450.

In vitro drug interaction studies in human liver microsomes indicate that inhibitors of CYP2D6 such as fluoxetine and its metabolite norfluoxetine, amitriptyline, and quinidine inhibit the metabolism of tramadol to various degrees.

The principal cytochrome P450 isoenzyme involved appears to be CYP2E1, with CYP1A2 and CYP3A4 as additional pathways.

Adverse reactions

Adverse reactions (US label) US FDA label

ADVERSE REACTIONS Table 2 reports the incidence rate of treatment-emergent adverse events over five days of tramadol hydrochloride and acetaminophen tablets use in clinical trials (subjects took an average of at least 6 tablets per day). Table 2: Incidence of Treatment-Emergent Adverse Events (≥2%) Body System Preferred Term Tramadol Hydrochloride and Acetaminophen Tablets (N=142) % Gastrointestinal System Disorders Constipation 6 Diarrhea 3 Nausea 3 Dry Mouth 2 Psychiatric Disorders Somnolence 6 Anorexia 3 Insomnia 2 Central & Peripheral Nervous System Dizziness 3 Skin and Appendages Sweating Increased 4 Pruritus 2 Reproductive Disorders, Male * Prostatic Disorder 2 * Number of males = 62 Incidence at least 1%, causal relationship at least possible or greater: the following lists adverse reactions that occurred with an incidence of at least 1% in single-dose or repeated-dose clinical trials of tramadol hydrochloride and acetaminophen tablets.

Body as a Whole – Asthenia, fatigue, hot flushes Central and Peripheral Nervous System – Dizziness, headache, tremor Gastrointestinal System – Abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting Psychiatric Disorders – Anorexia, anxiety, confusion, euphoria, insomnia, nervousness, somnolence Skin and Appendages – Pruritus, rash, increased sweating. Selected Adverse events occurring at less than 1%: the following lists clinically relevant adverse reactions that occurred with an incidence of less than 1% in tramadol hydrochloride and acetaminophen tablets clinical trials.

Body as a Whole – Chest pain, rigors, syncope, withdrawal syndrome Cardiovascular Disorders – Hypertension, aggravated hypertension, hypotension Central and Peripheral Nervous System – Ataxia, convulsions, hypertonia, migraine, aggravated migraine, involuntary muscle contractions, paresthesias, stupor, vertigo Gastrointestinal System – Dysphagia, melena, tongue edema Hearing and Vestibular Disorders – Tinnitus Heart Rate and Rhythm Disorders – Arrhythmia, palpitation, tachycardia Liver and Biliary System – Hepatic function abnormal Metabolic and Nutritional Disorders – Weight decrease Psychiatric Disorders – Amnesia, depersonalization, depression, drug abuse, emotional lability, hallucination, impotence, paroniria, abnormal thinking Red Blood Cell Disorders – Anemia Respiratory System – Dyspnea Urinary System – Albuminuria, micturition disorder, oliguria, urinary retention Vision Disorders – Abnormal vision Other clinically significant adverse experiences previously reported with tramadol hydrochloride: Other events which have been reported with the use of tramadol products and for which a causal association has not been determined include: vasodilation, orthostatic hypotension, myocardial ischemia, pulmonary edema, allergic reactions (including anaphylaxis and urticaria, Stevens-Johnson syndrome/TENS), cognitive dysfunction, difficulty concentrating, depression, suicidal tendency, hepatitis, liver failure and gastrointestinal bleeding. Reported laboratory abnormalities included elevated creatinine and liver function tests.

Serotonin syndrome (whose symptoms may include mental status change, hyperreflexia, fever, shivering, tremor, agitation, diaphoresis, seizures and coma) has been reported with tramadol when used concomitantly with other serotonergic agents such as SSRIs and MAOIs. Other clinically significant adverse experiences previously reported with acetaminophen: Allergic reactions (primarily skin rash) or reports of hypersensitivity secondary to acetaminophen are rare and generally controlled by discontinuation of the drug and, when necessary, symptomatic treatment.

Adverse reaction frequency tables (US label) US FDA label
Table 2: Incidence of Treatment-Emergent Adverse Events (≥2%)
Body System Preferred TermTramadol Hydrochloride and Acetaminophen Tablets (N=142) %
Gastrointestinal System Disorders
Constipation6
Diarrhea3
Nausea3
Dry Mouth2
Psychiatric Disorders
Somnolence6
Anorexia3
Insomnia2
Central & Peripheral Nervous System
Dizziness3
Skin and Appendages
Sweating Increased4
Pruritus2
Reproductive Disorders, Male *
Prostatic Disorder2

Pharmacokinetics

Half-life and elimination (verbatim, US label)

Tramadol has a slower absorption and longer half-life when compared to acetaminophen.

Parameter a (+)-Tramadol (-)-Tramadol (+)-M1 (-)-M1 acetaminophen C max (ng/mL) 64.3 (9.3) 55.5 (8.1) 10.9 (5.7) 12.8 (4.2) 4.2 (0.8) t max (h) 1.8 (0.6) 1.8 (0.7) 2.1 (0.7) 2.2 (0.7) 0.9 (0.7) CL/F (mL/min) 588 (226) 736 (244) - - - - 365 (84) t ½ (h) 5.1 (1.4) 4.7 (1.2) 7.8 (3) 6.2 (1.6) 2.5 (0.6) a For acetaminophen, C max was measured as mcg/mL.

Approximately 30% of the dose is excreted in the urine as unchanged drug, whereas 60% of the dose is excreted as metabolites.

The apparent plasma elimination half-life of racemic tramadol increased to 7 to 9 hours upon multiple dosing of tramadol hydrochloride and acetaminophen tablets.

The half-life of acetaminophen is about 2 to 3 hours in adults.

Pharmacokinetics (US label) US FDA label

CLINICAL PHARMACOLOGY The following information is based on studies of tramadol alone or acetaminophen alone, except where otherwise noted: Pharmacodynamics Tramadol hydrochloride and acetaminophen tablets contain tramadol hydrochloride and acetaminophen. Tramadol is a centrally acting synthetic opioid analgesic. Although its mode of action is not completely understood, from animal tests, at least two complementary mechanisms appear applicable: binding of parent and M1 metabolite to µ-opioid receptors and weak inhibition of reuptake of norepinephrine and serotonin.

Opioid activity is due to both low affinity binding of the parent compound and higher affinity binding of the O-demethylated metabolite M1 to µ-opioid receptors. In animal models, M1 is up to 6 times more potent than tramadol in producing analgesia and 200 times more potent in µ-opioid binding. Tramadol-induced analgesia is only partially antagonized by the opiate antagonist naloxone in several animal tests.

The relative contribution of both tramadol and M1 to human analgesia is dependent upon the plasma concentrations of each compound (see CLINICAL PHARMACOLOGY, Pharmacokinetics). Tramadol has been shown to inhibit reuptake of norepinephrine and serotonin in vitro, as have some other opioid analgesics. These mechanisms may contribute independently to the overall analgesic profile of tramadol.

Apart from analgesia, tramadol administration may produce a constellation of symptoms (including dizziness, somnolence, nausea, constipation, sweating and pruritus) similar to that of other opioids. Acetaminophen is a non-opiate, non-salicylate analgesic. Pharmacokinetics Tramadol is administered as a racemate and both the [-] and [+] forms of both tramadol and M1 are detected in the circulation.

The pharmacokinetics of plasma tramadol and acetaminophen following oral administration of one tramadol hydrochloride and acetaminophen tablet are shown in Table 1. Tramadol has a slower absorption and longer half-life when compared to acetaminophen. Table 1: Summary of Mean (±SD) Pharmacokinetic Parameters of the (+)- and (-) Enantiomers of Tramadol and M1 and Acetaminophen Following A Single Oral Dose Of One Tramadol Hydrochloride and Acetaminophen Combination Tablet (37.5 mg/325 mg) in Volunteers.

Parameter a (+)-Tramadol (-)-Tramadol (+)-M1 (-)-M1 acetaminophen C max (ng/mL) 64.3 (9.3) 55.5 (8.1) 10.9 (5.7) 12.8 (4.2) 4.2 (0.8) t max (h) 1.8 (0.6) 1.8 (0.7) 2.1 (0.7) 2.2 (0.7) 0.9 (0.7) CL/F (mL/min) 588 (226) 736 (244) - - - - 365 (84) t ½ (h) 5.1 (1.4) 4.7 (1.2) 7.8 (3) 6.2 (1.6) 2.5 (0.6) a For acetaminophen, C max was measured as mcg/mL. A single-dose pharmacokinetic study of tramadol hydrochloride and acetaminophen tablets in volunteers showed no drug interactions between tramadol and acetaminophen.

Upon multiple oral dosing to steady-state, however, the bioavailability of tramadol and metabolite M1 was lower for the combination tablets compared to tramadol administered alone. The decrease in AUC was 14% for (+)-tramadol, 10.4% for (-)-tramadol, 11.9% for (+)-M1 and 24.2% for (-)-M1. The cause of this reduced bioavailability is not clear.

Following single- or multiple-dose administration of tramadol hydrochloride and acetaminophen tablets, no significant change in acetaminophen pharmacokinetics was observed when compared to acetaminophen given alone. Absorption The absolute bioavailability of tramadol from tramadol hydrochloride and acetaminophen tablets has not been determined.

Tramadol hydrochloride has a mean absolute bioavailability of approximately 75% following administration of a single 100 mg oral dose of tramadol hydrochloride tablets. The mean peak plasma concentration of racemic tramadol and M1 after administration of two tramadol hydrochloride and acetaminophen tablets occurs at approximately two and three hours, respectively, post-dose.

Peak plasma concentrations of acetaminophen occur within one hour and are not affected by co-administration with tramadol. Oral absorption of acetaminophen following administration of tramadol hydrochloride and acetaminophen tablets occurs primarily in the small intestine. Food Effects When tramadol hydrochloride and acetaminophen tablets were administered with food, the time to peak plasma concentration was delayed for approximately 35 minutes for tramadol and almost one hour for acetaminophen.

However, peak plasma concentrations, and the extents of absorption, of tramadol and acetaminophen were not affected. The clinical significance of this difference is unknown. Distribution The volume of distribution of tramadol was 2.6 and 2.9 L/kg in male and female subjects, respectively, following a 100 mg intravenous dose.

The binding of tramadol to human plasma proteins is approximately 20% and binding also appears to be independent of concentration up to 10 mcg/mL. Saturation of plasma protein binding occurs only at concentrations outside the clinically relevant range. Acetaminophen appears to be widely distributed throughout most body tissues except fat.

Its apparent volume of distribution is about 0.9 L/kg. A relative small portion (~20%) of acetaminophen is bound to plasma protein. Metabolism Following oral administration, tramadol is extensively metabolized by a number of pathways, including CYP2D6 and CYP3A4, as well as by conjugation of parent and metabolites. Approximately 30% of the dose is excreted in the urine as unchanged drug, whereas 60% of the dose is excreted as metabolites.

The major metabolic pathways appear to be N - and O - demethylation and glucuronidation or sulfation in the liver. Metabolite M1 (O -desmethyltramadol) is pharmacologically active in animal models. Formation of M1 is dependent on CYP2D6 and as such is subject to inhibition, which may affect the therapeutic response (see PRECAUTIONS, Drug Interactions).

Approximately 7% of the population has reduced activity of the CYP2D6 isoenzyme of cytochrome P450. These individuals are “poor metabolizers” of debrisoquine, dextromethorphan, tricyclic antidepressants, among other drugs. Based on a population PK analysis of Phase 1 studies in healthy subjects, concentrations of tramadol were approximately 20% higher in “poor metabolizers” versus “extensive metabolizers”, while M1 concentrations were 40% lower.

In vitro drug interaction studies in human liver microsomes indicate that inhibitors of CYP2D6 such as fluoxetine and its metabolite norfluoxetine, amitriptyline, and quinidine inhibit the metabolism of tramadol to various degrees. The full pharmacological impact of these alterations in terms of either efficacy or safety is unknown.

Concomitant use of SEROTONIN re-uptake INHIBITORS and MAO INHIBITORS may enhance the risk of adverse events, including seizure (see WARNINGS) and serotonin syndrome. Acetaminophen is primarily metabolized in the liver by first-order kinetics and involves three principal separate pathways: a) conjugation with glucuronide; b) conjugation with sulfate; and c) oxidation via the cytochrome, P450-dependent, mixed-function oxidase enzyme pathway to form a reactive intermediate metabolite, which conjugates with glutathione and is then further metabolized to form cysteine and mercapturic acid conjugates.

The principal cytochrome P450 isoenzyme involved appears to be CYP2E1, with CYP1A2 and CYP3A4 as additional pathways. In adults, the majority of acetaminophen is conjugated with glucuronic acid and, to a lesser extent, with sulfate. These glucuronide-, sulfate-, and glutathione-derived metabolites lack biologic activity.

In premature infants, newborns, and young infants, the sulfate conjugate predominates. Elimination Tramadol is eliminated primarily through metabolism by the liver and the metabolites are eliminated primarily by the kidneys. The plasma elimination half-lives of racemic tramadol and M1 are approximately 5 to 6 and 7 hours, respectively, after administration of tramadol hydrochloride and acetaminophen tablets.

The apparent plasma elimination half-life of racemic tramadol increased to 7 to 9 hours upon multiple dosing of tramadol hydrochloride and acetaminophen tablets. The half-life of acetaminophen is about 2 to 3 hours in adults. It is somewhat shorter in children and somewhat longer in neonates and in cirrhotic patients. Acetaminophen is eliminated from the body primarily by formation of glucuronide and sulfate conjugates in a dose-dependent manner.

Less than 9% of acetaminophen is excreted unchanged in the urine. Special Populations Renal The pharmacokinetics of tramadol hydrochloride and acetaminophen in patients with renal impairment has not been studied. Based on studies using tramadol alone, excretion of tramadol and metabolite M1 is reduced in patients with creatinine clearance of less than 30 mL/min.

Adjustment of dosing regimen in this patient population is recommended (see DOSAGE AND ADMINISTRATION). The total amount of tramadol and M1 removed during a 4-hour dialysis period is less than 7% of the administered dose based on studies using tramadol alone. Hepatic The pharmacokinetics and tolerability of tramadol hydrochloride and acetaminophen in patients with impaired hepatic function have not been studied.

Since tramadol and acetaminophen are both extensively metabolized by the liver, the use of tramadol hydrochloride and acetaminophen in patients with hepatic impairment is not recommended (see PRECAUTIONS and DOSAGE AND ADMINISTRATION). Geriatric A population pharmacokinetic analysis of data obtained from a clinical trial in patients with chronic pain treated with tramadol hydrochloride and acetaminophen, which included 55 patients between 65 and 75 years of age and 19 patients over 75 years of age, showed no significant changes in the pharmacokinetics of tramadol and acetaminophen in elderly patients with normal renal and hepatic function (see PRECAUTIONS, Geriatric Use).

Gender Tramadol clearance was 20% higher in female subjects compared to males on four phase I studies of tramadol hydrochloride and acetaminophen in 50 male and 34 female healthy subjects. The clinical significance of this difference is unknown. Pediatric The pharmacokinetics of tramadol hydrochloride and acetaminophen tablets has not been studied in pediatric patients below 16 years of age.

Clinical Studies Single-Dose Studies for Treatment of Acute Pain In pivotal single-dose studies in acute pain, two tablets of tramadol hydrochloride and acetaminophen administered to patients with pain following oral surgical procedures provided greater relief than placebo or either of the individual components given at the same dose. The onset of pain relief after tramadol hydrochloride and acetaminophen was faster than tramadol alone.

Onset of analgesia occurred in less than one hour. The duration of pain relief after tramadol hydrochloride and acetaminophen tablets was longer than acetaminophen alone. Analgesia was generally comparable to that of the comparator, ibuprofen.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Tramadol Hydrochloride and Acetaminophen · AvPAK [US FDA-approved label, version 6, January 12, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=244f6e5d-e1b4-ba8b-ca6f-af2d8a31d5f0
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .